Sponsored by

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 501 to 525 of about 5882

Previous 25

Website Changes

05/16/2022

Webinar video about `How to speed up the search for the cure of brain tumors` posted to website!

05/16/2022

Cancer Commons Presents Free Educational Webinar for Caregivers May 18, 2022

05/13/2022

Musella Foundation Copay Assistance program is running low on funding

05/13/2022

DCVax-L Phase 3 Clinical Trial Results - Video Posted!

05/13/2022

National Walks To End Brain Tumors This Weekend!

05/13/2022

Musella Foundation Brain Tumor Awareness Month Webinar Series!

05/12/2022

Mount Sinai Neurosurgeon Elected as First Female Chair of North America’s Preeminent Brain Tumor Association

05/11/2022

FDA Recommends Early Progression to Phase 3 Trials for Sitoiganap for Glioblastoma Treatment

05/10/2022

The long awaited results of the double blind, randomized, placebo controlled Phase III clinical trial with DCVax-L for newly diagnosed GBM was just released! The slides of the results presentation are now on my website at virtualtrials.org/dcvax #GBM #BTAM #DCVAX

05/08/2022

Phase 3 Trial of Chemoradiotherapy With Temozolomide Plus Nivolumab or Placebo for Newly Diagnosed Glioblastoma With Methylated MGMT Promoter

04/24/2022

Musella Foundation Brain Tumor Awareness Month Webinar Series!

04/21/2022

Blood-brain barrier-penetrating single CRISPR-Cas9 nanocapsules for effective and safe glioblastoma gene therapy

04/20/2022

Tumor Treating Fields: killing two birds with one stone

04/20/2022

Black Diamond Therapeutics Announces First Patient Dosed in Phase 1 Study of BDTX-1535, a MasterKey Inhibitor of EGFR for the Treatment of Glioblastoma and Non-Small Cell Lung Cancer

04/14/2022

Mustang Bio Announces a Phase 1 Clinical Trial Combining MB-101 (IL13Ra2-targeted CAR T cell therapy) and MB-108 (C134 oncolytic virus)

04/12/2022

The UCLA Brain Tumor Center is hosting the 2022 UCLA Brain Tumor Virtual Conference on Friday, May 6th from 8:00am to 5:00pm (Pacific Time).

04/10/2022

Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma

04/10/2022

Upfront Molecular Targeted Therapy for the Treatment of BRAF-Mutant Pediatric High-Grade Glioma

04/03/2022

Advanced MRI Imaging

04/02/2022

Tessa Jowell`s brain tumour zapper could give mother-of-two Nancy, 47, more precious time with her family... but the NHS said the £240,000-a-year treatment is not `cost effective`

04/01/2022

Temozolomide and Radiotherapy vs Radiotherapy Alone in IDH-Wildtype Glioblastoma

03/26/2022

Nagoya University Researchers Develop Highly Accurate MicroRNA Urine Test That Identifies Brain Cancer in Patients with Tumors

03/26/2022

Cyclist Goes the Extra Mile to Help Conquer Brain Cancer

03/25/2022

Updated 2-THE-TOP Data Suggest Improvements in Progression-Free Survival, Overall Survival Compared to Matched-Control Patients from EF-14 Trial

03/23/2022

Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient-level data from 4 prospective trials

Our privacy / cookie policy has changed.
Click HERE to read it!